As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
We are very excited to launch our new website! Please take a few moments to click around and explore...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
We have now added a new section called the "Assay History List" to the "At A Gla...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...